Hexedrone, frequently referred to as a designer drug, represents {a developing challenge within the party drug landscape. First appearing in Europe markets , this synthetic chemical is suspected to be a structural analogue of copyright, though its definitive effects and long-term medical consequences remain largely undetermined. Information suggest